Correlation Between Apellis Pharmaceuticals and Stoke Therapeutics
Can any of the company-specific risk be diversified away by investing in both Apellis Pharmaceuticals and Stoke Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apellis Pharmaceuticals and Stoke Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apellis Pharmaceuticals and Stoke Therapeutics, you can compare the effects of market volatilities on Apellis Pharmaceuticals and Stoke Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apellis Pharmaceuticals with a short position of Stoke Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apellis Pharmaceuticals and Stoke Therapeutics.
Diversification Opportunities for Apellis Pharmaceuticals and Stoke Therapeutics
0.82 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Apellis and Stoke is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Apellis Pharmaceuticals and Stoke Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Stoke Therapeutics and Apellis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apellis Pharmaceuticals are associated (or correlated) with Stoke Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Stoke Therapeutics has no effect on the direction of Apellis Pharmaceuticals i.e., Apellis Pharmaceuticals and Stoke Therapeutics go up and down completely randomly.
Pair Corralation between Apellis Pharmaceuticals and Stoke Therapeutics
Given the investment horizon of 90 days Apellis Pharmaceuticals is expected to generate 1.18 times more return on investment than Stoke Therapeutics. However, Apellis Pharmaceuticals is 1.18 times more volatile than Stoke Therapeutics. It trades about 0.19 of its potential returns per unit of risk. Stoke Therapeutics is currently generating about -0.04 per unit of risk. If you would invest 2,734 in Apellis Pharmaceuticals on August 28, 2024 and sell it today you would earn a total of 457.00 from holding Apellis Pharmaceuticals or generate 16.72% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Apellis Pharmaceuticals vs. Stoke Therapeutics
Performance |
| Timeline |
| Apellis Pharmaceuticals |
| Stoke Therapeutics |
Apellis Pharmaceuticals and Stoke Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Apellis Pharmaceuticals and Stoke Therapeutics
The main advantage of trading using opposite Apellis Pharmaceuticals and Stoke Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apellis Pharmaceuticals position performs unexpectedly, Stoke Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Stoke Therapeutics will offset losses from the drop in Stoke Therapeutics' long position.| Apellis Pharmaceuticals vs. Eliem Therapeutics | Apellis Pharmaceuticals vs. HCW Biologics | Apellis Pharmaceuticals vs. Scpharmaceuticals | Apellis Pharmaceuticals vs. Milestone Pharmaceuticals |
| Stoke Therapeutics vs. Adaptimmune Therapeutics Plc | Stoke Therapeutics vs. Black Diamond Therapeutics | Stoke Therapeutics vs. Relay Therapeutics | Stoke Therapeutics vs. Pliant Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |